Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51


Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.

Gadad BS, Jha MK, Czysz A, Furman JL, Mayes TL, Emslie MP, Trivedi MH.

J Affect Disord. 2017 Jul 5. pii: S0165-0327(17)30671-7. doi: 10.1016/j.jad.2017.07.001. [Epub ahead of print] Review.


Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

de Sousa RT, Loch AA, Carvalho AF, Brunoni AR, Haddad MR, Henter ID, Zarate CA, Machado-Vieira R.

Neuropsychopharmacology. 2017 Mar;42(4):787-800. doi: 10.1038/npp.2016.149. Epub 2016 Aug 11. Review.


5-HT2A Gene Variants Moderate the Association between PTSD and Reduced Default Mode Network Connectivity.

Miller MW, Sperbeck E, Robinson ME, Sadeh N, Wolf EJ, Hayes JP, Logue M, Schichman SA, Stone A, Milberg W, McGlinchey R.

Front Neurosci. 2016 Jun 28;10:299. doi: 10.3389/fnins.2016.00299. eCollection 2016.


Review of Cohort Studies for Mood Disorders.

Jeon HJ, Baek JH, Ahn YM, Kim SJ, Ha TH, Cha B, Moon E, Kang HJ, Ryu V, Cho CH, Heo JY, Kim K, Lee HJ; Mood Disorders Cohort Research Consortium (MDCRC) Group.

Psychiatry Investig. 2016 May;13(3):265-76. doi: 10.4306/pi.2016.13.3.265. Epub 2016 May 18. Review.


Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci.

Smith DJ, Escott-Price V, Davies G, Bailey ME, Colodro-Conde L, Ward J, Vedernikov A, Marioni R, Cullen B, Lyall D, Hagenaars SP, Liewald DC, Luciano M, Gale CR, Ritchie SJ, Hayward C, Nicholl B, Bulik-Sullivan B, Adams M, Couvy-Duchesne B, Graham N, Mackay D, Evans J, Smith BH, Porteous DJ, Medland SE, Martin NG, Holmans P, McIntosh AM, Pell JP, Deary IJ, O'Donovan MC.

Mol Psychiatry. 2016 Jun;21(6):749-57. doi: 10.1038/mp.2016.49. Epub 2016 Apr 12.


Severity of Depression Predicts Remission Rates Using Transcranial Magnetic Stimulation.

Grammer GG, Kuhle AR, Clark CC, Dretsch MN, Williams KA, Cole JT.

Front Psychiatry. 2015 Sep 1;6:114. doi: 10.3389/fpsyt.2015.00114. eCollection 2015.


Analysis of pharmacogenomic variants associated with population differentiation.

Yeon B, Ahn E, Kim KI, Kim IW, Oh JM, Park T.

PLoS One. 2015 Mar 25;10(3):e0119994. doi: 10.1371/journal.pone.0119994. eCollection 2015.


GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.

Kawaguchi DM, Glatt SJ.

Pharmacogenomics. 2014 Aug;15(11):1451-9. doi: 10.2217/pgs.14.96.


Genetic prediction of antidepressant drug response and nonresponse in Korean patients.

Lim SW, Won HH, Kim H, Myung W, Kim S, Kim KK, Carroll BJ, Kim JW, Kim DK.

PLoS One. 2014 Sep 16;9(9):e107098. doi: 10.1371/journal.pone.0107098. eCollection 2014.


Towards the clinical implementation of pharmacogenetics in bipolar disorder.

Salloum NC, McCarthy MJ, Leckband SG, Kelsoe JR.

BMC Med. 2014 May 30;12:90. doi: 10.1186/1741-7015-12-90.


From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Fabbri C, Porcelli S, Serretti A.

Can J Psychiatry. 2014 Feb;59(2):62-75. Review.


Detecting local haplotype sharing and haplotype association.

Xu H, Guan Y.

Genetics. 2014 Jul;197(3):823-38. doi: 10.1534/genetics.114.164814. Epub 2014 May 8.


Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

Reynolds GP, McGowan OO, Dalton CF.

Br J Clin Pharmacol. 2014 Apr;77(4):654-72. doi: 10.1111/bcp.12312. Review.


Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.

Lester KJ, Eley TC.

Biol Mood Anxiety Disord. 2013 Feb 7;3(1):4. doi: 10.1186/2045-5380-3-4.


Systemic injection of kainic acid differently affects LTP magnitude depending on its epileptogenic efficiency.

Suárez LM, Cid E, Gal B, Inostroza M, Brotons-Mas JR, Gómez-Domínguez D, de la Prida LM, Solís JM.

PLoS One. 2012;7(10):e48128. doi: 10.1371/journal.pone.0048128. Epub 2012 Oct 31.


Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response.

Hodgson K, Mufti SJ, Uher R, McGuffin P.

Genome Med. 2012 Jun 27;4(6):52. doi: 10.1186/gm351.


Predicting psychotherapy benefit: a probabilistic and individualized approach.

Lindhiem O, Kolko DJ, Cheng Y.

Behav Ther. 2012 Jun;43(2):381-92. doi: 10.1016/j.beth.2011.08.004. Epub 2011 Aug 28.


Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice.

Catches JS, Xu J, Contractor A.

Behav Brain Res. 2012 Mar 17;228(2):406-14. doi: 10.1016/j.bbr.2011.12.026. Epub 2011 Dec 22.


Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Kupfer DJ, Frank E, Phillips ML.

Lancet. 2012 Mar 17;379(9820):1045-55. doi: 10.1016/S0140-6736(11)60602-8. Epub 2011 Dec 19. Review.

Supplemental Content

Support Center